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Abstract
Double aneuploidy mosaicism of two different aneuploidy cell lines is rare. We describe for the first time a double
trisomy mosaicism, involving chromosomes 7 and 13 in a fetus presenting with multiple congenital anomalies. No
evidence for chimerism was found by DNA genotyping. The origin of both trisomies are consistent with isodisomy
of maternal origin. Therefore, it is most likely that the double trisomy mosaicism arose from two independent
events very early in embryonic development. The trisomy 7 and 13 cells were shown to be of maternal origin.
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Background
Double aneuploidy mosaicism of two different aneu-
ploidy cell lines is a rare event [1]. The most frequently
described combinations ar eam o n o s o m yXc e l ll i n e
with a cell line containing a trisomy of an autosome. In
literature, mosaicism of a monosomy X cell line with
either a trisomy 7, 8, 10, 13, 18 or 21 have been
reported [2-7]. Double autosomal trisomies are even
more sporadic, and to date combinations of trisomies of
the chromosomes 8 and 14, chromosomes 8 and 21,
chromosomes 13 and 18, chromosomes 13 and 21, and
chromosomes 18 and 21 have been reported [1,8-12].
Here, we present the first report of a double trisomy
mosaicism involving chromosomes 7 and 13 in both
amniotic fluid and subsequent FISH analysis of fibroblasts
in a fetus presenting with multiple congenital anomalies.
Case presentation
A 17-year-old healthy woman of a non-consanguineous
couple, gravida 1, para 0, was referred at 21+0 weeks’
gestation because of multiple structural anomalies.
There was no history of familial congenital anomalies or
drug use. The pregnancy was unplanned but welcome.
A dating scan had been performed at 8 weeks’ gestation.
A 12 weeks’ scan was not performed since the parents
did not wish screening for Down syndrome. The fetus
showed growth restriction with a large bilateral cleft lip
and palate with severe micrognathia. The caput showed
mild brachycephaly, with an enlarged cisterna magna (>
p95). The left little finger was bowed and there were
mild clubfeet. Following genetic counselling the patient
elected to have an amniocentesis for karyotyping. More-
over, the parents requested a termination of pregnancy.
Labour was induced at 22+2 weeks and a female baby
was born, who died shortly after birth. Her birth weight
was 370 g. Autopsy confirmed the bilateral cleft lip and
palate as well as the retrognathia, and revealed an internal
malrotation of the digestive tract with the ileocecal valve
situated in the upper abdomen on the left side and bicor-
nate uterus. All body and organ measures were within
normal range for the given gestational age. X-ray showed
no developmental anomalies of the skeletal system. Brain
autopsy found no cerebral developmental anomalies,
except for microglial upregulation, most likely as a result
of hypoxic damage. Finally, the placenta showed no
abnormalities, with the exception of a slight degeneration.
Fetal chromosome analysis of in situ cultured amnio-
cytes revealed a double trisomy mosaicism: mos 47, XX,
+7[6]/47, XX, +13[18]. A trisomy 13 was seen in 75% of
the amniocytes (18/24 metaphases) and in three differ-
ent cultures. The remaining 25% of the cells (6/24 meta-
phases) showed a trisomy 7, also in two different
cultures. There was no cell line with a normal
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both chromosome 13 and 7.
FISH analysis of fetal skin tissue obtained after
autopsy confirmed the trisomy 7 and trisomy 13 mosai-
cism. FISH was performed with probes for chromosome
7 (Abbott-Vysis CEP 7, 7p11.1-q11.1) and chromosome
13 (Abbott-Vysis LSI 13 RB1, 13q14.2) (Figure 1). The
hybridization pattern shows 26% trisomy 7 and disomy
13 (41/159 interphase cells). Another 70% showed dis-
omy 7 and trisomy 13 (111/159 interphase cells). In 4%
(7/159 interphase cells) a normal signal pattern was
seen (disomy 7 and disomy 13). This may represent a
true disomy for chromosomes 7 and 13, or a FISH arte-
fact. There were no cells with both trisomy 7 and 13,
similar to the findings in the amniotic fluid earlier.
DNA genotyping using 16 STR markers (Powerplex 16
kit Promega) showed the presence of a single maternal
and a single paternal allele in the DNA extracted from
amniotic fluid cells for all informative markers, without
evidence for chimerism (paternal allele, 14 markers
informative; maternal allele 9 markers informative), sug-
gesting that the trisomy 7 and the trisomy 13 cell lines
were not a result of two different zygotes.
Theoretically, several mechanisms may have lead to
this mosaic pattern of both trisomy 7 and trisomy 13
cells in a single fetus (Figure 2). First, two independent
non-disjunction events may have taken place in a 46,
XX zygote. However, no cells in amniotic fluid and only
4% of cells in fetal tissue with a normal karyotype were
detected. Second, two independent losses (anaphase
lagging) may have occurred in a 48, XX, +7, +13 zygote.
This option does not seem likely, since no cells were
detected with a trisomy for both chromosome 13 and 7.
A third option is a trisomic fetus with either a trisomy 7
or 13. In a part of the cells, trisomic rescue may occur,
followed by a non-disjunction event, resulting in a fetus
with two different trisomic cell lines.
To establish the origin of the chromosomes 7 and 13,
DNA analyses was performed. Seven markers for chro-
mosome 13 (D13S217, D13S171, D13S263, D13S159,
D13S158, D13S173, D13S285) were informative and
showed an increased contribution of the maternally
inherited allele (confirmed by QF-PCR, Tepnel). Also,
four informative chromosome 7 markers (D7S664,
D7S2427, D7S2476, D7S483) showed an increased con-
tribution of the maternally inherited allele. The results
are consistent with an isodisomy 7 and an isodisomy 13
of maternal origin. Since no heterodisomic markers
were seen, a postfertilization error very early in embryo-
nic development seems most plausible. In literature, no
evidence was found for higher risks for chromosomal
trisomies in women under the age of 20 [13].
Mosaic trisomy 7 is not an unusual finding in chorionic
villus sampling, but rarely confirmed at amniocentesis. To
our knowledge, trisomy 7 mosaicism has been described
in about 18 patients, half of which were regarded as clini-
cally normal. However, in a majority of those patients, the
trisomy 7 is seen in skin fibroblasts, but not in lympho-
cytes. Common features are pigmentary changes of the
skin, facial asymmetry and short palpebral fissures [14].
Figure 1 Interphase FISH results. FISH was performed with probes for chromosome 7 (Abbott-Vysis CEP 7, 7p11.1-q11.1, spectrum green) and
chromosome 13 (Abbott-Vysis LSI 13 RB1, 13q14.2, spectrum orange). The left panel shows a cell with a trisomy 7 and a disomy 13. The right
panel displays a cell with a trisomy 13 and a disomy 7.
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association [14,15]. In the current fetus, the ultrasound
findings and anomalies seen at autopsy seem more in con-
cordance with a (mosaic) trisomy 13, rather than with a
(mosaic) trisomy 7 (table 1).
Conclusions
We describe a double aneuploid foetus with two differ-
ent trisomic cell lines: one with a trisomy 7 (approxi-
mately 26%) and one with a trisomy 13 (approximately
70%). No evidence for chimerism was found by DNA
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Figure 2 Possible mechanism for the origin of double aneuploidy mosaicism in this fetus. Schematic representation of the mechanisms
that may have lead to a mosaic pattern of both trisomy 7 and trisomy 13 cells in a single fetus. Two independent non-disjunction events may
have taken place in a 46, XX zygote, resulting in both a trisomy 7 cell line (26%) and a trisomy 13 cell line (70%). Both monosomic cells are not
viable. In fetal tissue, 4% of the cells in fetal tissue showed a normal signal pattern with FISH.
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with isodisomy of maternal origin. Therefore, it is most
likely that the double aneuploidy seen arose from two
independent events very early in embryonic
development.
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Table 1 Contribution of trisomy 7 and trisomy 13 cells to
the abnormalities seen at autopsy.
Congenital abnormality assumed to be attributed by
trisomy of chromosome
bilateral cleft lip and palate 7/13
micrognathia/retrognathia 13
enlarged cisterna magna 7/13
left little finger bowed 13
mild clubfeet 7/13
malrotation of the digestive tract 13
bicornate uterus 13
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